Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spleen-kidney yang enhancement is a therapeutic strategy in Traditional Chinese Medicine, aimed at restoring physiological functions associated with Spleen and Kidney yang, understood as the sources of metabolic energy and warmth in the body[4][5][6][9]. This pattern is thought to manifest as chronic fatigue, digestive disturbances (diarrhea, poor absorption), edema, metabolic syndrome, immune dysregulation, and kidney dysfunction[1][2][4][5][8][9]. Treatment involves the use of tonic herbal formulations, aiming to improve ATPase activity, digestive enzyme balance, immune function, and energy metabolism. While animal and clinical models examine associated changes in enzyme activities, immune biomarkers, and metabolic parameters, there is no canonical molecular entity or receptor named "spleen-kidney yang" in Western biomedicine[2][4][9].
Enhancement of ATPase activities (Na⁺-K⁺-ATPase, Ca²⁺-Mg²⁺-ATPase) in animal models. Modulation of digestive enzymes (amylase, sucrase, lactase). Immune system regulation (macrophage activity, Treg/TGFβ1 modulation, anti-inflammatory actions). Energy metabolism improvement and antioxidation (e.g., glutathione levels).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spleen-kidney yang enhancement.